P2 receptors: Intracellular signaling

Pflugers Archiv European Journal of Physiology

Volumn 452, Issue 5, 2006, Pages 552-562

  Erb, Laurie ^a   Liao, Zhongji ^a   Seye, Cheikh I ^a   Weisman, Gary A ^a  

^a University of Missouri   (United States)

Author keywords

ATP receptors; G proteins; G protein coupled receptors; Ion channels; Purinergic receptors; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; CALCIUM ION; CELL ADHESION MOLECULE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MONOMER; NUCLEOTIDE DERIVATIVE; PHOSPHODIESTERASE; PHOSPHOLIPASE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINE P2Y14 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CELL DIFFERENTIATION; CELL MEMBRANE TRANSPORT; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CELL SECRETION; CYTOPLASM; ELECTRIC POTENTIAL; HUMAN; ION TRANSPORT; MUSCLE CONTRACTILITY; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM; GTP-BINDING PROTEINS; HUMANS; MODELS, NEUROLOGICAL; NEURONS; RECEPTORS, PURINERGIC P2; SYNAPTIC TRANSMISSION;

EID: 33745745473     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-006-0069-2     Document Type: Review

References (152)

1. Adinolfi E, Kim M, Young MT, Di Virgilio F, Surprenant A (2003) Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem 278:37344-37351
2. Aga M, Watters JJ, Pfeiffer ZA, Wiepz GJ, Sommer JA, Bertics PJ (2004) Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. Am J Physiol Cell Physiol 286:C923-C930
3. Ahn JS, Camden JM, Schrader AM, Redman RS, Turner JT (2000) Reversible regulation of P2Y(2) nucleotide receptor expression in the duct-ligated rat submandibular gland. Am J Physiol Cell Physiol 279:C286-C294
4. Amstrup J, Novak I (2003) P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx. Biochem J 374:51-61
5. Ayyanathan K, Webbs TE, Sandhu AK, Athwal RS, Barnard EA, Kunapuli SP (1996) Cloning and chromosomal localization of the human P2Y1 purinoceptor. Biochem Biophys Res Commun 218:783-788
6. Bagchi S, Liao Z, Gonzalez FA, Chorna NE, Seye CI, Weisman GA, Erb L (2005) The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration. J Biol Chem 280:39050-39057
7. Balsinde J, Winstead MV, Dennis EA (2002) Phospholipase A (2) regulation of arachidonic acid mobilization. FEBS Lett 531:2-6
8. Baltensperger K, Porzig H (1997) The P2U purinoceptor obligatorily engages the heterotrimeric G protein G16 to mobilize intracellular Ca2+ in human erythroleukemia cells. J Biol Chem 272:10151-10159
9. Bardoni R, Goldstein PA, Lee CJ, Gu JG, MacDermott A (1997) ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord. J Neurosci 17:5297-304
10. Bean BP (1992) Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol Sci 13:87-90
11. Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, Harden TK (2003) Purification and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 64:1210-1216
12. Boue-Grabot E, Archambault V, Seguela P (2000) A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels. J Biol Chem 275:10190-10195
13. Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371:519-523
14. Brown DA, Filippov AK, Barnard EA (2000) Inhibition of potassium and calcium currents in neurones by molecularly defined P2Y receptors. J Auton Nerv Syst 81:31-36
15. Budagian V, Bulanova E, Brovko L, Orinska Z, Fayad R et al (2003) Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem 278:1549-1560
16. Bulanova E, Budagian V, Orinska Z, Hein M, Petersen F et al (2005) Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 174:3880-3890
17. Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24:509-581
18. Burnstock G (2004) Introduction: P2 receptors. Curr Top Med Chem 4:793-803
19. Burrell HE, Bowler WB, Gallagher JA, Sharpe GR (2003) Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 120:440-447
20. Camden JM, Schrader AM, Camden RE, Gonzalez FA, Erb L et al (2005) P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing. J Biol Chem 280:18696-18702
21. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K et al (2000) A G protein-coupled receptor for UDP-glucose. J Biol Chem 275:10767-10771
22. Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT et al (2004) P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91:119-132
23. Chow YW, Wang HL (1998) Functional modulation of P2X2 receptors by cyclic AMP-dependent protein kinase. J Neurochem 70:2606-2612
24. Clarke LL, Boucher RC (1992) Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. Am J Physiol 263:C348-5C36
25. Clarke LL, Harline MC, Gawenis LR, Walker NM, Turner JT, Weisman GA (2000) Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium. Am J Physiol Gastrointest Liver Physiol 279:G132-G138
26. Clarke LL, Harline MC, Otero MA, Glover GG, Garrad RC et al (1999) Desensitization of P2Y2 receptor-activated transepithelial anion secretion. Am J Physiol 276:C777-C787
27. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y et al (2000) Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407:1011-1015
28. Communi D, Gonzalez NS, Detheux M, Brezillon S, Lannoy V et al (2001) Identification of a novel human ADP receptor coupled to G(i). J Biol Chem 276:41479-41485
29. Communi D, Govaerts C, Parmentier M, Boeynaems JM (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969-31973
30. Communi D, Motte S, Boeynaems JM, Pirotton S (1996) Pharmacological characterization of the human P2Y4 receptor. Eur J Pharmacol 317:383-389
31. Communi D, Parmentier M, Boeynaems JM (1996) Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun 222:303-308
32. Communi D, Pirotton S, Parmentier M, Boeynaems JM (1995) Cloning and functional expression of a human uridine nucleotide receptor. J Biol Chem 270:30849-30852
33. Cressman VL, Lazarowski E, Homolya L, Boucher RC, Koller BH, Grubb BR (1999) Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(-) transport. J Biol Chem 274:26461-26468
34. Denlinger LC, Fisette PL, Sommer JA, Watters JJ, Prabhu U et al (2001) Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 167:1871-1876
35. Denlinger LC, Sommer JA, Parker K, Gudipaty L, Fisette PL et al (2003) Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol 171:1304-1311
36. Dorn G, Patel S, Wotherspoon G, Hemmings-Mieszczak M, Barclay J et al (2004) siRNA relieves chronic neuropathic pain. Nucleic Acids Res 32:e49
37. Dubyak GR, el-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577-C606
38. Edwards FA, Gibb AJ, Colquhoun D (1992) ATP receptor-mediated synaptic currents in the central nervous system (see comment). Nature 359:144-147
39. Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC et al (2001) An RGD sequence in the P2Y(2) receptor interacts with alpha (V)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol 153:491-501
40. Erb L, Lustig KD, Ahmed AH, Gonzalez FA, Weisman GA (1990) Covalent incorporation of 3′-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts. J Biol Chem 265:7424-7431
41. Felder CC, Williams HL, Axelrod J (1991) A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. Proc Natl Acad Sci U S A 88:6477-6480
42. Feng YH, Wang L, Wang Q, Li X, Zeng R, Gorodeski GI (2005) ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor. Am J Physiol Cell Physiol 288:C1342-C1356
43. Filippov AK, Simon J, Barnard EA, Brown DA (2003) Coupling of the nucleotide P2Y4 receptor to neuronal ion channels. Br J Pharmacol 138:400-406
44. Filippov AK, Webb TE, Barnard EA, Brown DA (1997) Inhibition by heterologously expressed P2Y2 nucleotide receptors of N-type calcium currents in rat sympathetic neurones. Br J Pharmacol 121:849-851
45. Flores RV, Hernandez-Perez MG, Aquino E, Garrad RC, Weisman GA, Gonzalez FA (2005) Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor. Mol Cell Biochem 280:35-45
46. Garcia-Guzman M, Soto F, Gomez-Hernandez JM, Lund PE, Stuhmer W (1997) Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol Pharmacol 51:109-118
47. Garcia-Guzman M, Stuhmer W, Soto F (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. Brain Res Mol Brain Res 47:59-66
48. Garrad RC, Otero MA, Erb L, Theiss PM, Clarke LL et al (1998) Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus. J Biol Chem 273:29437-29444
49. Gendron FP, Chalimoniuk M, Strosznajder J, Shen S, Gonzalez FA et al (2003) P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem 87:344-352
50. Gendron FP, Neary JT, Theiss PM, Sun GY, Gonzalez FA, Weisman GA (2003) Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol 284:C571-C581
51. Gerwins P, Fredholm BB (1992) ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. J Biol Chem 267:16081-16087
52. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285:1028-1032
53. Godecke S, Decking UK, Godecke A, Schrader J (1996) Cloning of the rat P2u receptor and its potential role in coronary vasodilation. Am J Physiol 270:C570-C577
54. Greig AV, James SE, McGrouther DA, Terenghi G, Burnstock G (2003) Purinergic receptor expression in the regeneration epidermis in a rat model of normal and delayed wound healing. Exp Dermatol 12:860-871
55. Greig AV, Linge C, Cambrey A, Burnstock G (2003) Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 121:1145-1149
56. Gudipaty L, Munetz J, Verhoef PA, Dubyak GR (2003) Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am J Physiol Cell Physiol 285:C286-C299
57. Hall RA, Ostedgaard LS, Premont RT, Blitzer JT, Rahman N et al (1998) A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A 95:8496-8501
58. Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105:3552-3560
59. Hoebertz A, Mahendran S, Burnstock G, Arnett TR (2002) ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling. J Cell Biochem 86:413-419
60. Hollopeter G, Jantzen HM, Vincent D, Li G, England L et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207
61. Hou M, Harden TK, Kuhn CM, Baldetorp B, Lazarowski E et al (2002) UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol 282:H784-H792
62. Hou M, Moller S, Edvinsson L, Erlinge D (1999) MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. Biochem Biophys Res Commun 258:648-652
63. Hu Y, Fisette PL, Denlinger LC, Guadarrama AG, Sommer JA et al (1998) Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 273:27170-27175
64. Kellerman D, Evans R, Mathews D, Shaffer C (2002) Inhaled P2Y2 receptor agonists as a treatment for patients with cystic fibrosis lung disease. Adv Drug Deliv Rev 54:1463-1474
65. Khakh BS, Henderson G (1998) ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Mol Pharmacol 54:372-378
66. Kim M, Jiang LH, Wilson HL, North RA, Surprenant A (2001) Proteomic and functional evidence for a P2X7 receptor signalling complex. Embo J 20:6347-6358
67. Korcok J, Raimundo LN, Ke HZ, Sims SM, Dixon SJ (2004) Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts. J Bone Miner Res 19:642-651
68. Koshiba M, Apasov S, Sverdlov V, Chen P, Erb L et al (1997) Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Natl Acad Sci USA 94:831-836
69. Kunapuli SP, Ding Z, Dorsam RT, Kim S, Murugappan S, Quinton TM (2003) ADP receptors - targets for developing antithrombotic agents. Curr Pharm Des 9:2303-2316
70. Kunapuli SP, Dorsam RT, Kim S, Quinton TM (2003) Platelet purinergic receptors. Curr Opin Pharmacol 3:175-180
71. Lazarowski ER, Watt WC, Stutts MJ, Boucher RC, Harden TK (1995) Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate. Br J Pharmacol 116:1619-1627
72. Le KT, Paquet M, Nouel D, Babinski K, Seguela P (1997) Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system. FEBS Lett 418:195-199
73. Le Stunff H, Auger R, Kanellopoulos J, Raymond MN (2004) The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem 279:16918-16926
74. Lee SY, Wolff SC, Nicholas RA, O'Grady SM (2003) P2Y receptors modulate ion channel function through interactions involving the C-terminal domain. Mol Pharmacol 63:878-885
75. Liebmann C (2004) G protein-coupled receptors and their signaling pathways: classical therapeutical targets susceptible to novel therapeutic concepts. Curr Pharm Des 10:1937-1958
76. Lin JW, Sugimori M, Llinas RR, McGuinness TL, Greengard P (1990) Effects of synapsin I and calcium/calmodulin-dependent protein kinase II on spontaneous neurotransmitter release in the squid giant synapse. Proc Natl Acad Sci U S A 87:8257-8261
77. Liu J, Liao Z, Camden J, Griffin KD, Garrad RC et al (2004) Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279:8212-8218
78. Lustig KD, Sportiello MG, Erb L, Weisman GA (1992) A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP. Biochem J 284(Pt 3):733-739
79. Lynch KJ, Touma E, Niforatos W, Kage KL, Burgard EC et al (1999) Molecular and functional characterization of human P2X(2) receptors. Mol Pharmacol 56:1171-1181
80. Malam-Souley R, Seye C, Gadeau AP, Loirand G, Pillois X et al (1996) Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol 166:57-65
81. Marteau F, Le Poul E, Communi D, Labouret C, Savi P et al (2003) Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64:104-112
82. Martin KA, Kertesy SB, Dubyak GR (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 51:97-108
83. Megson AC, Dickenson JM, Townsend-Nicholson A, Hill SJ (1995) Synergy between the inositol phosphate responses to transfected human adenosine A1-receptors and constitutive P2-purinoceptors in CHO-K1 cells. Br J Pharmacol 115:1415-1424
84. Meshki J, Tuluc F, Bredetean O, Ding Z, Kunapuli SP (2004) Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am J Physiol Cell Physiol 286:C264-C271
85. Meyer CH, Hotta K, Peterson WM, Toth CA, Jaffe GJ (2002) Effect of INS37217, a P2Y(2) receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits. Invest Ophthalmol Vis Sci 43:3567-3574
86. Miyagi Y, Kobayashi S, Ahmed A, Nishimura J, Fukui M, Kanaide H (1996) P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. Biochem Biophys Res Commun 222:652-658
87. Moers A, Nieswandt B, Massberg S, Wettschureck N, Gruner S et al (2003) G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9:1418-1422
88. Mundell SJ, Benovic JL (2000) Selective regulation of endogenous G protein-coupled receptors by arrestins in HEK293 cells. J Biol Chem 275:12900-12908
89. Murthy KS, Makhlouf GM (1998) Coexpression of ligand-gated P2X and G protein-coupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC)-beta1 via Galphaq/11 and to PLC-beta3 via Gbetagammai3. J Biol Chem 273:4695-4704
90. Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J Cell Physiol 195:234-240
91. Nguyen T, Erb L, Weisman GA, Marchese A, Heng HH et al (1995) Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene. J Biol Chem 270:30845-30848
92. North RA (1996) P2X receptors: a third major class of ligand-gated ion channels. Ciba Found Symp 198:91-105
93. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067
94. North RA, Surprenant A (2000) Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40:563-580
95. Otero M, Garrad RC, Velazquez B, Hernandez-Perez MG, Camden JM et al (2000) Mechanisms of agonist-dependent and - independent desensitization of a recombinant P2Y2 nucleotide receptor. Mol Cell Biochem 205:115-123
96. Oury C, Toth-Zsamboki E, Vermylen J, Hoylaerts MF (2002) P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen. Blood 100:2499-2505
97. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D et al (2001) P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21:7135-7142
98. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH et al (1994) Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci U S A 91:3275-3279
99. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317
100. Pearson PJ, Evora PR, Schaff HV (1992) Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg 54:1078-1084
101. Pearson PJ, Lin PJ, Schaff HV (1992) Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. J Thorac Cardiovasc Surg 103:1147-1154
102. Qi AD, Kennedy C, Harden TK, Nicholas RA (2001) Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase. Br J Pharmacol 132:318-326
103. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
104. Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A (1997) The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 272:5482-5486
105. Robaye B, Boeynaems JM, Communi D (1997) Slow desensitization of the human P2Y6 receptor. Eur J Pharmacol 329:231-236
106. Santiago-Perez LI, Flores RV, Santos-Berrios C, Chorna NE, Krugh B et al (2001) P2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases. J Cell Physiol 187:196-208
107. Schafer R, Sedehizade F, Welte T, Reiser G (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 285:L376-L385
108. Schrader AM, Camden JM, Weisman GA (2005) P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjogren's syndrome. Arch Oral Biol 50:533-540
109. Selbie LA, King NV, Dickenson JM, Hill SJ (1997) Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. Biochem J 328(Pt 1):153-158
110. Seye CI, Gadeau AP, Daret D, Dupuch F, Alzieu P et al (1997) Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17:3602-3610
111. Seye CI, Kong Q, Erb L, Garrad RC, Krugh B et al (2002) Functional P2Y2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106:2720-2726
112. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA (2004) The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279:35679-35686
113. Seye CI, Yu N, Jain R, Kong Q, Minor T et al (2003) The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278:24960-24965
114. Simon J, Webb TE, King BF, Burnstock G, Barnard EA (1995) Characterisation of a recombinant P2Y purinoceptor. Eur J Pharmacol 291:281-289
115. Smart ML, Gu B, Panchal RG, Wiley J, Cromer B et al (2003) P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem 278:8853-8860
116. Soltoff SP, Avraham H, Avraham S, Cantley LC (1998) Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 273:2653-2660
117. Soulet C, Sauzeau V, Plantavid M, Herbert JM, Pacaud P et al (2004) Gi-dependent and -independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost 2:135-146
118. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738
119. Swanson KD, Reigh C, Landreth GE (1998) ATP-stimulated activation of the mitogen-activated protein kinases through ionotrophic P2X2 purinoreceptors in PC12 cells. Difference in purinoreceptor sensitivity in two PC12 cell lines. J Biol Chem 273:19965-19971
120. Tolhurst G, Vial C, Leon C, Gachet C, Evans RJ, Mahaut-Smith MP (2005) Interplay between P2Y(1), P2Y(12), and P2X(1) receptors in the activation of megakaryocyte cation influx currents by ADP: evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling. Blood 106:1644-1651
121. Tominaga M, Wada M, Masu M (2001) Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 98:6951-6956
122. Tonetti M, Sturla L, Bistolfi T, Benatti U, De Flora A (1994) Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 203:430-435
123. Tonetti M, Sturla L, Giovine M, Benatti U, De Flora A (1995) Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 214:125-130
124. Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S et al (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424:778-783
125. Tu MT, Luo SF, Wang CC, Chien CS, Chiu CT et al (2000) P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br J Pharmacol 129:1481-1489
126. Turner JT, Weisman GA, Camden JM (1997) Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture. Am J Physiol 273:C1100-C1107
127. Turner JT, Weisman GA, Landon LA, Park M, Camden JM (1998) Salivary gland nucleotide receptors: evidence for functional expression of both P2X and P2Y subtypes. Eur J Morphol 36(Suppl):170-175
128. Urano T, Nishimori H, Han H, Furuhata T, Kimura Y et al (1997) Cloning of P2XM, a novel human P2X receptor gene regulated by p53. Cancer Res 57:3281-3287
129. Valera S, Hussy N, Evans RJ, Adami N, North RA et al (1994) A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371:516-519
130. Velazquez B, Garrad RC, Weisman GA, Gonzalez FA (2000) Differential agonist-induced desensitization of P2Y2 nucleotide receptors by ATP and UTP. Mol Cell Biochem 206:75-89
131. Verhoef PA, Estacion M, Schilling W, Dubyak GR (2003) P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol 170:5728-5738
132. Vial C, Rolf MG, Mahaut-Smith MP, Evans RJ (2002) A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 135:363-372
133. Vial C, Tobin AB, Evans RJ (2004) G-protein-coupled receptor regulation of P2X1 receptors does not involve direct channel phosphorylation. Biochem J 382:101-110
134. Virginio C, MacKenzie A, North RA, Surprenant A (1999) Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol 519(2):335-346
135. Waldo GL, Harden TK (2004) Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. Mol Pharmacol 65:426-436
136. Wang M, Kong Q, Gonzalez FA, Sun G, Erb L et al (2005) P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration. J Neurochem 95:630-640
137. Weisman GA, Garrad RC, Erb LJ, Otero M, Gonzalez FA, Clarke LL (1998) Structure and function of P2Y2 nucleotide receptors in cystic fibrosis (CF) epithelium. Adv Exp Med Biol 431:417-424
138. Welch BD, Carlson NG, Shi H, Myatt L, Kishore BK (2003) P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. Am J Physiol Renal Physiol 285:F711-F721
139. Werry TD, Christie MI, Dainty IA, Wilkinson GF, Willars GB (2002) Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells. Br J Pharmacol 135:1199-1208
140. White PJ, Kumari R, Porter KE, London NJ, Ng LL, Boarder MR (2000) Antiproliferative effect of UTP on human arterial and venous smooth muscle cells. Am J Physiol Heart Circ Physiol 279:H2735-H2742
141. White PJ, Webb TE, Boarder MR (2003) Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling. Mol Pharmacol 63:1356-1363
142. Wilden PA, Agazie YM, Kaufman R, Halenda SP (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275:H1209-H1215
143. Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ et al (2003) An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. J Biol Chem 278:17108-17113
144. Wilkinson GF, Purkiss JR, Boarder MR (1994) Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells. Mol Pharmacol 45:731-736
145. Wilson HL, Wilson SA, Surprenant A, North RA (2002) Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem 277:34017-34023
146. Xing M, Post S, Ostrom RS, Samardzija M, Insel PA (1999) Inhibition of phospholipase A2-mediated arachidonic acid release by cyclic AMP defines a negative feedback loop for P2Y receptor activation in Madin-Darby canine kidney D1 cells. J Biol Chem 274:10035-10038
147. Xu J, Chalimoniuk M, Shu Y, Simonyi A, Sun AY et al (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot Essent Fat Acids 69:437-448
148. Xu J, Weng YI, Simonyi A, Krugh BW, Liao Z et al (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. J Neurochem 83:259-270
149. Yerxa BR, Sabater JR, Davis CW, Stutts MJ, Lang-Furr M et al (2002) Pharmacology of INS37217 [P(1)-(uridine 5′)-P(4)- (2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 302:871-880
150. Yoshioka K, Saitoh O, Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617-7622
151. Zhang FL, Luo L, Gustafson E, Lachowicz J, Smith M et al (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276:8608-8615
152. Zhang FL, Luo L, Gustafson E, Palmer K, Qiao X et al (2002) P2Y(13): identification and characterization of a novel Galphai-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301:705-713